Making medical decisions optimally is akin to making economic decisions and is founded on a simple framework: EUT, or Expected Utility Theory. To determine whether to pursue a course of action versus another one, we add up the benefits of a course multiplied by their probability of accruing (that product is the positive utility of the course of action) and then subtract the product of the costs of the course of action and their probability of accruing (the negative utility). If utility is positive, we pursue a course of action, and if options are available, we pursue the course with the highest positive utility. Ideally, anybody helping you navigate such a decision framework would tell you the numbers so you could do the calculus. Using the finance analogy again, if the adviser told you "Stocks have positive returns. So do bonds. Stocks are riskier than bonds" - without any quantification, you may conclude that a portfolio full of bonds is the best course of action - and usually it is not.
I regret to report that that is exactly what clinical practice guideline writers do: provide summary information without any numerical data to support it, leaving the practitioner with two choices: